Market Overview

UPDATE: Canaccord Genuity Upgrades Bed Bath & Beyond to Buy on Cost Plus Catalyst

Related BBBY
Mixed Economic Data, Ebola Scares Rattle Markets
#PreMarket Primer: Friday, September 26: US Coalition Picks Up A New Supporter
Nasdaq Crumbles in Worst Rout Since '11 (Fox Business)

Canaccord Genuity raised its rating on Bed Bath & Beyond (NASDAQ: BBBY) from Hold to Buy and increased its price target from $71 to $75.

Canaccord Genuity noted, "BBBY shares have declined 15% since 6/20 when the company issued Q2 EPS guidance that fell short of expectations. … We view this as an opportunity for investors to buy a high-quality company just as the addition of Cost Plus becomes a potential growth lever. We believe Cost Plus' contribution to EPS will grow from $0.01 in F2012 to $0.32 by F2016. BBBY still has around $1B in cash following recent acquisitions which will support much-needed investments in technology and the return of capital to shareholders."

Bed Bath & Beyond closed at $62.78 on Friday.

Latest Ratings for BBBY

DateFirmActionFromTo
Oct 2014Credit SuisseAssumesNeutral
Sep 2014Bank of AmericaReiteratesUnderperform
Sep 2014NomuraMaintainsNeutral

View More Analyst Ratings for BBBY
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (BBBY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters